Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Pfizer's Pneumococcal Conjugate Vaccine Awarded Breakthrough Therapy Designation
Pfizer's Pneumococcal Conjugate Vaccine Awarded Breakthrough Therapy Designation
Pfizer's Pneumococcal Conjugate Vaccine Awarded Breakthrough Therapy Designation
Submitted by
admin
on September 20, 2018 - 9:37am
Source:
CP Wire
News Tags:
Pfizer
streptococcus pneumoniae
vaccines
breakthrough therapies
FDA
Headline:
Pfizer's Pneumococcal Conjugate Vaccine Awarded Breakthrough Therapy Designation
snippet:
The vaccine was awarded fast-track status by the FDA in October of 2017
Pfizer expects to start Phase 3 trials in a few months
Do Not Allow Advertisers to Use My Personal information
